Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy L Macdonald

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Circulation Research|September 9, 2006
Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptorAngela M Whetzel, David T Bolick, Suseela Srinivasan, et al.
Bioorganic & Medicinal Chemistry|November 23, 2006
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonistsFrank W Foss, Ashley H Snyder, Michael D Davis, et al.
Journal of Medicinal Chemistry|November 13, 2007
Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonistRan Zhu, Ashley H Snyder, Yugesh Kharel, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2016
Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and EpsilonproteobacteriaAndrew J Kennedy, Alexandra M Bruce, Catherine Gineste, et al.
Journal of Medicinal Chemistry|April 5, 2002
Biological activity of the tryprostatins and their diastereomers on human carcinoma cell linesShuo Zhao, Kirsten S Smith, Amy Morin Deveau, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptorsFrank W Foss, Jeremy J Clemens, Michael D Davis, et al.
Medchemcomm|December 20, 2011
Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonistJames E East, Karen M Carter, Perry C Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonistsWilliam F McCalmont, Tiffany N Heady, Jaclyn R Patterson, et al.
American Journal of Physiology. Renal Physiology|January 13, 2006
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidneyAlaa S Awad, Hong Ye, Liping Huang, et al.
Chemmedchem|January 29, 2011
Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activityT Eric Ballard, Xia Wang, Igor Olekhnovich, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Circulation Research|September 9, 2006
Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptorAngela M Whetzel, David T Bolick, Suseela Srinivasan, et al.
Bioorganic & Medicinal Chemistry|November 23, 2006
Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonistsFrank W Foss, Ashley H Snyder, Michael D Davis, et al.
Journal of Medicinal Chemistry|November 13, 2007
Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonistRan Zhu, Ashley H Snyder, Yugesh Kharel, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2016
Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and EpsilonproteobacteriaAndrew J Kennedy, Alexandra M Bruce, Catherine Gineste, et al.
Journal of Medicinal Chemistry|April 5, 2002
Biological activity of the tryprostatins and their diastereomers on human carcinoma cell linesShuo Zhao, Kirsten S Smith, Amy Morin Deveau, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptorsFrank W Foss, Jeremy J Clemens, Michael D Davis, et al.
Medchemcomm|December 20, 2011
Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonistJames E East, Karen M Carter, Perry C Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonistsWilliam F McCalmont, Tiffany N Heady, Jaclyn R Patterson, et al.
American Journal of Physiology. Renal Physiology|January 13, 2006
Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidneyAlaa S Awad, Hong Ye, Liping Huang, et al.
Chemmedchem|January 29, 2011
Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activityT Eric Ballard, Xia Wang, Igor Olekhnovich, et al.
Pageof 8